Table 4.
Immune Cell Subset | Leukocytes | Lymphocytes | |||||
---|---|---|---|---|---|---|---|
Coefficient | 95% CI | p Value | Coefficient | 95% CI | p Value | ||
Sex | Male | Reference | - | - | Reference | - | - |
Female | −0.4 ± 0.9 | −1.1 to 1.0 | 0.93 | 0.0 ± 0.1 | −0.2 to 0.3 | 0.71 | |
Age, years | - | - | 0.74 | - | - | 0.003 | |
<55 | Reference | - | - | Reference | - | - | |
55–64 | −0.5 ± 0.9 | −2.2 to 1.3 | - | −0.3 ± 0.2 | −0.7 to 0.1 | - | |
65–74 | −0.4 ± 0.8 | −2.0 to 1.3 | - | −0.4 ± 0.2 | −0.7 to 0.0 | - | |
75–84 | −0.7 ± 0.9 | −2.4 to 1.0 | - | −0.5 ± 0.2 | −0.9 to −0.1 | - | |
>84 | 0.5 ± 1.1 | −1.7 to 2.6 | - | −0.6 ± 0.2 | −1.1 to −0.2 | - | |
Disease modality (TIA vs. AIS) | 1.5 ± 0.5 | 0.4 to 2.6 | 0.006 | −0.1 ± 0.1 | −0.3 to 0.2 | 0.66 | |
National Institutes of Health Stroke Scale | - | - | 0.11 | - | - | 0.052 | |
0–4 | Reference | - | - | Reference | - | - | |
5–9 | 0.8 ± 0.8 | −0.7 to 2.3 | - | −0.3 ± 0.2 | −0.6 to 0.1 | - | |
10–15 | 0.8 ± 0.9 | −0.9 to 2.6 | - | −0.1 ± 0.2 | −0.5 to 0.3 | - | |
>15 | 1.3 ± 1.0 | −0.8 to 3.3 | - | −0.5 ± 0.2 | −1.0 to −0.1 | - | |
Thrombolysis | 0.1 ± 0.7 | −1.3 to 1.4 | 0.94 | 0.1 ± 0.2 | −0.20 to 0.4 | 0.53 | |
Use of platelet inhibitor before blood taking | 0.5 ± 0.5 | −0.6 to 1.6 | 0.34 | 0.2 ± 0.1 | −0.1 to 0.4 | 0.17 |
AIS, acute ischemic stroke; CI, confidence interval; TIA, transient ischemic stroke.